TSVT - 2seventy bio GAAP EPS of -$1.11 misses by $0.06 revenue of $10.68M misses by $4.51M
2024-03-05 07:04:54 ET
More on 2seventy bio
- 2seventy bio: An Overload Of Troubles At This Small Pharma
- Bristol Myers, 2seventy bio to face FDA panel in March for Abecma decision
- Leerink ups 2seventy to outperform, cites attractiveness as takeover target
- Seeking Alpha’s Quant Rating on 2seventy bio
- Historical earnings data for 2seventy bio